Literature DB >> 1154809

Metabolism of papaverine. II. Species differences.

F M Belpaire, M G Bogaert.   

Abstract

1. The urinary and biliary excretion of radioactive products in a 6 hr period after intravenous administration of [3H]papaverine was studied in rat, guinea-pig, rabbit, cat and dog. All species excreted metabolites extensively in the bile; only in rabbit and guinea-pig is urinary excretion important. 2. Metabolites in urine and bile of all species studied are mainly monophenolic compounds conjugated to glucuronic or sulphuric acid. Differences in the excretion patterns of the metabolites between different species are only quantitative. 3. Blood or plasma levels of papaverine after intravenous injection decreased with half-lives of approximately 12, 15, 22, 60 and 60 min for rabbit, rat, guinea-pig, cat and dog, respectively. The metabolites disappeared much more slowly than papaverine from the plasma. 4. Binding of papaverine to plasma proteins, as studied by equilibrium dialysis, was more than 90% in all species.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1154809     DOI: 10.3109/00498257509056112

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.

Authors:  Zhude Tu; Jinbin Xu; Lynne A Jones; Shihong Li; Robert H Mach
Journal:  Nucl Med Biol       Date:  2010-03-06       Impact factor: 2.408

2.  Papaverine increases human serum albumin glycation.

Authors:  Alireza Ahmadzadeh
Journal:  J Biol Phys       Date:  2014-01-12       Impact factor: 1.365

3.  Toxicity assessment of papaverine hydrochloride and papaverine-derived metabolites in primary cultures of rat hepatocytes.

Authors:  J C Davila; C G Reddy; P J Davis; D Acosta
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

4.  The fate of drotaverine-acephyllinate in rat and man. II. Human pharmacokinetics of drotaverine-14C-acephyllinate.

Authors:  Z Vargay; T Deutsch; I Szatmári; T Szüts; P Várkonyi; S Kerpel-Fronius; S Eckhardt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.